The Neurobiology of Anxiety and Limitations of Current Treatments Anxiety disorders ,encompassing generalized anxiety disorder, social anxiety disorder, panic disorder, and specific phobias ,collectively represent the most prevalent mental health condition category in the United States, affecting approximately 40 million adults annually. Despite decades of pharmacological development and the availability of multiple approved treatments, anxiety … [Read more…]
Fibromyalgia: Reframing a Misunderstood Condition Fibromyalgia is one of the most prevalent yet most fundamentally misunderstood chronic conditions in clinical medicine. Affecting approximately 4 million American adults ,with a female-to-male ratio of approximately 3:1 ,fibromyalgia produces a symptom complex that extends far beyond the widespread musculoskeletal pain most commonly associated with the diagnosis. Profound fatigue, … [Read more…]
Understanding RLS: Beyond ‘Just a Feeling’ Restless Legs Syndrome ,formally recognized as Willis-Ekbom Disease by neurological societies to honor its original describers ,is a neurological sensorimotor disorder affecting 5–10% of American adults, making it one of the most common neurological conditions in the population. Despite its prevalence, RLS remains systematically underdiagnosed: patients often struggle for … [Read more…]
Epilepsy and the Challenge of Adequate Seizure Control Epilepsy affects approximately 3.4 million Americans and is defined by the tendency to experience recurrent unprovoked seizures ,episodes of abnormal, synchronized electrical discharge in the brain that produce changes in consciousness, movement, sensation, or behavior depending on the brain regions involved. Despite the availability of more than … [Read more…]
The Shingles-to-PHN Progression: Understanding Why Pain Outlasts the Rash Herpes zoster ,commonly known as shingles ,affects approximately 1 million Americans annually, caused by reactivation of the varicella-zoster virus that has remained dormant in dorsal root ganglia since a childhood chickenpox infection. For most patients, the painful acute rash resolves within two to four weeks with … [Read more…]
What Is Neuropathic Pain and Why Is It Different? Neuropathic pain is a distinct category of chronic pain that originates not from tissue injury or inflammation but from dysfunction or damage within the nervous system itself. Unlike nociceptive pain ,the protective alarm signal that alerts us to injury ,neuropathic pain is generated by malfunctioning neural … [Read more…]
Neuropathic Pain in Children: Underrecognized and Undertreated Neuropathic pain in children and adolescents is one of the most underrecognized pain categories in pediatric medicine ,reflecting both historical underestimation of complex pain in younger patients and relative paucity of pediatric-specific analgesic trials. Children experience neuropathic pain from chemotherapy-induced peripheral neuropathy, complex regional pain syndrome, post-surgical neuropathic … [Read more…]
CIPN: The Complication That Follows Patients After Cancer Treatment Ends Chemotherapy-induced peripheral neuropathy affects 30–70% of patients during treatment with neurotoxic chemotherapy agents and persists as a chronic condition in 30–40% of cancer survivors ,producing burning, tingling, numbness, allodynia, and balance impairment that accompanies survivors for years to decades after chemotherapy ends. Balance dysfunction from … [Read more…]
HIV-Associated Sensory Neuropathy: Scope and Mechanism HIV-associated sensory neuropathy (HIV-SN) is the most prevalent neurological complication of HIV infection, affecting 30–67% of people living with HIV ,including those on otherwise effective antiretroviral therapy. Its prevalence has not substantially declined in the antiretroviral era because mechanisms include both HIV’s direct neurotoxicity and the neurotoxicity of several … [Read more…]
Migraine: Neurological Disease Demanding Better Prevention Migraine affects 39 million Americans and ranks as the second leading cause of years lived with disability globally. For patients with four or more migraine days monthly, preventive pharmacological therapy is clinically indicated to reduce attack frequency, severity, and duration. Yet migraine remains dramatically undertreated ,only about 40% of … [Read more…]